Skip to main content
. 2020 Oct 6;23(6):1543–1578. doi: 10.1111/hex.13140

TABLE 4.

Results of subgroup analysis (n = 1236)

Male Female
Coefficient (SE) SD (SE) Coefficient (SE) SD (SE)
Effect 70% 1.486 (0.076)*** 0.593 (0.111)*** 1.544 (0.073)*** 0.225 (0.184)
Effect 90% 3.279 (0.147)*** 1.954 (0.129)*** 3.391 (0.149)*** 0.265 (0.187)***
Duration 12 mo 0.464 (0.06)*** 0.011 (0.101) 0.564 (0.059)*** 1.866 (0.131)
Duration 18 mo 0.601 (0.072)*** 0.351 (0.135)* 0.955 (0.079)*** 0.081 (0.116)***
Moderate adverse event 0.524 (0.062)*** 0.075 (0.136) 0.444 (0.07)*** 0.6 (0.123)***
No adverse event 0.951 (0.079)*** 0.93 (0.096)** 1.157 (0.085)*** 0.71 (0.1)***
Injection 2 times −0.04 (0.065) 0.319 (0.137) 0.164 (0.066)*** 1.156 (0.097)
Injection 1 time 0.076 (0.059) 0.066 (0.158) 0.286 (0.062)* 0.083 (0.115)*
Imported 0.198 (0.045)*** 0.085 (0.173) 0.176 (0.046)*** 0.317 (0.127)
Price −0.001 (0.001)*** 0.002 (0.001)*** −0.002 (0.001)*** 0.213 (0.113)***
Urban resident Rural resident
Coefficient (SE) SD (SE) Coefficient (SE) SD (SE)
Effect 70% 1.488 (0.058)*** 0.372 (0.102)*** 1.44 (0.11)*** 0.564 (0.191)**
Effect 90% 3.235 (0.109)*** 1.805 (0.101)*** 3.208 (0.227)*** 2.087 (0.233)***
Duration 12 mo 0.499 (0.047)*** 0.041 (0.086) 0.554 (0.089)*** 0.1 (0.148)
Duration 18 mo 0.718 (0.056)*** 0.326 (0.122)** 0.832 (0.118)** 0.683 (0.182)***
Moderate adverse event 0.528 (0.052)*** 0.423 (0.096)*** 0.324 (0.093)*** 0.196 (0.24)
No adverse event 1.043 (0.064)*** 0.933 (0.078)*** 1.137 (0.126)*** 0.968 (0.176)***
Injection 2 times 0.065 (0.051) 0.02 (0.148) 0.099 (0.095) 0.07 (0.178)
Injection 1 time 0.142 (0.048)** 0.144 (0.128) 0.323 (0.09)*** 0.309 (0.202)
Imported 0.154 (0.036)*** 0.299 (0.07)*** 0.331 (0.068)*** 0.192 (0.141)
Price −0.002 (0.001)*** 0.002 (0)*** −0.002 (0.001)*** 0.002 (0.001)***
Had children No children
Coefficient (SE) SD (SE) Coefficient (SE) SD (SE)
Effect 70% 1.558 (0.071)*** 0.448 (0.126)*** 1.411 (0.081)*** 0.517 (0.127)***
Effect 90% 3.426 (0.139)*** 2.015 (0.138)*** 3.001 (0.141)*** 1.782 (0.137)***
Duration 12 months 0.483 (0.057)*** 0.081 (0.098) 0.57 (0.065)*** 0.123 (0.118)
Duration 18 months 0.77 (0.072)*** 0.606 (0.113)*** 0.727 (0.076)*** 0.292 (0.215)
Moderate adverse event 0.546 (0.06)*** 0.072 (0.155) 0.413 (0.067)*** 0.211 (0.295)
No adverse event 0.991 (0.076)*** 0.947 (0.092)*** 1.176 (0.094)*** 1.092 (0.101)***
Injection 2 times 0.031 (0.062) 0.126 (0.129) 0.105 (0.069) 0.27 (0.145)
Injection 1 time 0.175 (0.058)* 0.336 (0.118)** 0.176 (0.063)* 0.115 (0.248)
Imported 0.169 (0.043)*** 0.286 (0.102)** 0.204 (0.049)*** 0.326 (0.088)***
Price −0.002 (0.001)*** 0.002 (0.001)*** −0.002 (0.001)*** 0.002 (0.001)***
Vaccinated Non‐vaccinated
Coefficient (SE) SD (SE) Coefficient (SE) SD (SE)
Effect 70% 1.601 (0.065)*** 0.212 (0.157) 1.259 (0.079)*** 0.584 (0.128)***
Effect 90% 3.434 (0.129)*** 1.911 (0.119) 2.912 (0.151)*** 1.809 (0.145)***
Duration 12 months 0.515 (0.053)*** 0.116 (0.108) 0.487 (0.066)*** 0.051 (0.118)
Duration 18 months 0.751 (0.066)*** 0.392 (0.142) 0.74 (0.081)*** 0.473 (0.128)***
Moderate adverse event 0.512 (0.057)*** 0.22 (0.167) 0.423 (0.071)*** 0.192 (0.133)
No adverse event 1.064 (0.077)*** 1.058 (0.088) 1.087 (0.088)*** 0.905 (0.107)***
Injection 2 times 0.037 (0.058) 0.211 (0.158) 0.094 (0.072) 0.091 (0.132)
Injection 1 time 0.149 (0.054)* 0.222 (0.151) 0.193 (0.067)* 0.228 (0.133)
Imported 0.179 (0.041)*** 0.175 (0.094) 0.194 (0.053)*** 0.45 (0.084)***
Price −0.002 (0.001)*** 0.002 (0.001) −0.002 (0.001)*** 0.002 (0.001)***

Abbreviations: SE, standard error; SD standard deviation.

*

<0.05;

**

<0.01;

***

<0.001.